Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains
- Megan C. Rich
- , Chesleigh N. Keene
- , Miriam D. Neher
- , Krista Johnson
- , Zhao Xue Yu
- , Antoine Ganivet
- , V. Michael Holers
- , Philip F. Stahel
Research output: Contribution to journal › Article › peer-review
36
Link opens in a new tab
Scopus
citations